Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation

Tsivgoulis G.; Katsanos A. H.; Seiffge D. J.; Paciaroni M.; Wilson D.; Koga M.; Macha K.; Cappellari M.; Kallmuenzer B.; Polymeris A. A.; Toyoda K.; Caso V; Werring D. J.; Engelter S. T.; De Marchis G. M.

首页> 外文期刊>European journal of neurology: the official journal of the European Federation of Neurological Societies >Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation

【24h】

Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation

机译：口腔抗凝治疗发生后发生致命的颅内出血，对心房颤动患者进行继发性脑卒中预防

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and purpose In this pooled analysis of seven multicentre cohorts potential differences were investigated in the incidence, characteristics and outcomes between intracranial haemorrhages (ICHs) associated with the use of non-vitamin K antagonist oral anticoagulants (NOAC-ICH) or with vitamin K antagonists (VKA-ICH) in ischaemic stroke patients after oral anticoagulant treatment initiation for atrial fibrillation (AF).

机译：None

著录项

来源
《European journal of neurology: the official journal of the European Federation of Neurological Societies》 |2020年第8期|共6页
作者
Tsivgoulis G.; Katsanos A. H.; Seiffge D. J.; Paciaroni M.; Wilson D.; Koga M.; Macha K.; Cappellari M.; Kallmuenzer B.; Polymeris A. A.; Toyoda K.; Caso V; Werring D. J.; Engelter S. T.; De Marchis G. M.;
展开▼
作者单位

Natl &

Kapodistrian Univ Athens Attikon Univ Hosp Dept Neurol 2 Sch Med Athens Greece;

McMaster Univ Div Neurol Populat Hlth Res Inst Hamilton ON Canada;

Univ Hosp Neurol &

Stroke Ctr Basel Switzerland;

Univ Perugia Stroke Unit Perugia Italy;

UCL Inst Neurol Stroke Res Ctr Dept Brain Repair &

Rehabil London England;

Natl Cerebral &

Cardiovasc Ctr Dept Cerebrovasc Med Suita Osaka Japan;

Univ Erlangen Nurnberg Dept Neurol Erlangen Germany;

Azienda Osped Univ Integrata Dept Neurosci Stroke Unit Verona Italy;

Univ Erlangen Nurnberg Dept Neurol Erlangen Germany;

Univ Hosp Neurol &

Stroke Ctr Basel Switzerland;

Natl Cerebral &

Cardiovasc Ctr Dept Cerebrovasc Med Suita Osaka Japan;

Univ Perugia Stroke Unit Perugia Italy;

UCL Inst Neurol Stroke Res Ctr Dept Brain Repair &

Rehabil London England;

Univ Hosp Neurol &

Stroke Ctr Basel Switzerland;

Univ Hosp Neurol &

Stroke Ctr Basel Switzerland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词
anticoagulation; cerebral haemorrhage; cerebral infarction; cerebrovascular diseases and cerebral circulation; neurological disorders;

机译：抗凝血;脑出血;脑梗死;脑血管疾病和脑循环;神经系统疾病;

相似文献

外文文献
中文文献
专利

1. Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associated stroke: An inpatient registration study in Shanghai [J] . Feng-Di Liu, Rong Zhao, Xue-Mei Wang, 慢性疾病与转化医学（英文） . 2015,第004期
2. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective,Observational Study [J] . Wei-Ping Huang, Yong-Hua Zhang, Lei He, 中华医学杂志（英文版） . 2017,第004期
3. Left atrial appendage closure in secondary prevention of stroke in a patient with atrial fibrillation as well as prior stroke and iatrogenic intracranial haemorrhage [J] . Anetta Lasek-Bal, Przemys?aw Puz Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej . 2012,第3期

机译：左心耳封堵在房颤以及既往中风和医源性颅内出血患者继发性中风的预防中
4. Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis? [J] . St?llbergerC., BastovanskyA., FinstererJ. Journal of thrombosis and thrombolysis . 2013,第4期

机译：新型口服抗凝剂在房颤和颅内狭窄中作为一级和二级卒中预防有作用吗？
5. Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis? [J] . St?llbergerC., BastovanskyA., FinstererJ. Journal of thrombosis and thrombolysis . 2013,第4期

机译：新的口腔抗凝血剂是心房颤动和颅内狭窄的主要和继发性脑卒中的作用吗？
6. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
7. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
8. Oral anticoagulants for primary prevention treatment and secondary prevention of venous thromboembolic disease and for prevention of stroke in atrial fibrillation: systematic review network meta-analysis and cost-effectiveness analysis. [O] . Jonathan Ac Sterne, Pritesh N Bodalia, Peter A Bryden, -1

机译：口服抗凝剂用于静脉血栓栓塞性疾病的一级预防治疗和二级预防以及在房颤中预防中风：系统评价网络荟萃分析和成本效益分析。
9. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation:systematic review, network meta-analysis and cost-effectiveness analysis [O] . Sterne Jonathan Ac, Bodalia Pritesh N, Bryden Peter A, 2017

机译：口服抗凝剂，用于静脉血栓栓塞性疾病的一级预防，治疗和二级预防，以及在房颤中预防中风：系统评价，网络荟萃分析和成本效益分析
10. Transition of Care for Acute Stroke and Myocardial Infarction Patients: From Hospitalization to Rehabilitation, Recovery, and Secondary Prevention. Executive Summary. Evidence Report/Technology Assessment Number 202 [R] . 2011

机译：急性卒中和心肌梗死患者的护理过渡：从住院到康复，康复和二级预防。执行摘要。证据报告/技术评估编号202

Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation

摘要

著录项

相似文献

相关主题

期刊订阅